Cardiac function and structure in longitudinal analysis of echocardiography in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 30, Issue 3, 2010, Pages 353-361

  Io, Hiroaki ^a   Ro, Yuuki ^a   Sekiguchi, Yoshimi ^a   Shimaoka, Tetsutaro ^a   Inuma, Jiro ^a   Hotta, Yoko ^a   Aruga, Seiki ^a   Inami, Yuko ^a   Sato, Michiko ^a   Kobayashi, Takashi ^a   Masuda, Atsumi ^a   Kaneko, Kayo ^a   Hamada, Chieko ^a   Ohtaki, Eiji ^b   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Ohtaki Heart Clinic   (Japan)

Author keywords

Atrial natriuretic peptide (ANP); Echocardiography; Left atrium (LA) size; Left ventricular mass index (LVMI)

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; RECOMBINANT ERYTHROPOIETIN;

ADD ON THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; FLUID INTAKE; FOLLOW UP; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE MASS; HEART MUSCLE COMPLIANCE; HEART STRUCTURE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INFERIOR CAVA VEIN; JAPAN; LONGITUDINAL STUDY; MALE; PATIENT; PATIENT MONITORING; PERITONEAL DIALYSIS PATIENT; PRIORITY JOURNAL; PROGNOSIS; UNIVERSITY HOSPITAL;

ADULT; ATRIAL FUNCTION, LEFT; ATRIAL NATRIURETIC FACTOR; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 77957663794     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00007     Document Type: Article

References (31)

1. Dastoor H, Bernieh B, Boobes Y, Abochacra S, Eltayeb E, Elhuda MN, et al. Plasma BNP in patients on maintenance hemodialysis: a guide to management? J Hypertens 2005; 23:23-8.
2. Takeichi N, Fukuda N, Tamura Y, Oki T, Ito S. Relationship between left atrium function and plasma level of atrial natriuretic peptide in patients with heart disease. Cardiology 1998; 90:13-19.
3. Triulzi MO, Castini D, Omaghi M, Vitolo E. Effects of preload reduction on mitral flow velocity pattern in normal subjects. Am J Cardiol 1990; 66:995-1001.
4. Jari AL, Sudhir K, Jaakko E, Matti H, Jukka TS. Left atrium size and the risk of cardiovascular death in middle-aged men. Arch Intern Med 2005; 165:1788-93.
5. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, cicconi B, et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2005; 38: 371-6.
6. Devereux RB, Alonso DR, Lutas EM. Echocardiographic assessment of left ventricular hypertrophy. Comparison to necropsy findings. Am J Cardiol 1986; 57:450-8.
7. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 1993; 65:212-14.
8. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthro-pometric measurements. Am J Clin Nutr 1980; 33:27-39.
9. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001; 40:1079-84.
10. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Hypertension 2002; 39:739-43.
11. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size: the Framingham heart study. Hypertension 1995; 25:1150-60.
12. Tsang TS, Barnes ME, Gersh BJ, Takemoto Y, Rosales AG, Bailey KR, et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 2003; 42: 1199-205.
13. Tamura T, Kawaguchi Y, Tojou K, Ohta M, Sugimoto K, Hosoya T. Clinical usefulness of Doppler echocardiography for the assessment of dry weight in dialysis patients with known heart disease. Jpn Soc Dial Ther 2000; 33:1409-16.
14. London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B. Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. Kidney Int Suppl 1993; 41:S42-9.
15. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58:1325-35.
16. Jeren-Strujic B, Raos V, Jeren T, Horvatin-Godler S. Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO). Angiology 2000; 51:131-9.
17. Huting J, Kramer W, Schutterle G, Wizemann V. Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. Nephron 1988; 49: 284-90.
18. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fauad-Tarazi F, et al. Sympathetic over activity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-18.
19. Nagano M, Higaki J, Mikami H. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J Hypertens 1991; 9:595-9.
20. Schmieder RE, Langenfeld MRW, Friedrich A. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94:1304-9.
21. Arnfried U, Markus S, Peter M. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115:41-6.
22. Harty J, Venning M, Gokal R. Does CAPD guarantee adequate dialysis and nutrition? Nephrol Dial Transplant 1994; 9:1721-3.
23. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 62:639-47.
24. Takeda K, Nakamoto M, Hirakata H, Baba M, Kubo M, Fujishima M. Disadvantage of long-term CAPD for preserving cardiac performance: an echocardiographic study. Am J Kidney Dis 1998; 32:482-7.
25. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JG, Stevens P, et al. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int 1999; 55:1476-85.
26. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16:35-44.
27. Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int Suppl 1993; 40:S106-10.
28. Mattioli AV, Bonatti S, Monopoli D, Zennaro M, Mattioli G. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension. Blood Press 2005; 14:273-8.
29. Bavbek N, Akay H, Altay M, Uz E, Turgut F, Uyar ME, et al. Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Perit Dial Int 2007; 27:663-8.
30. Rodrigues-Carmona A, Fontan MP. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis. Perit Dial Int 2002; 22:705-13.
31. Foley RN, Culleton BF, Parfrey PS, Harnett JD, Kent GM, Murray DC, et al. Cardiac disease in diabetic end-stage renal disease. Diabetologia 1997; 40:1307-12.